|
Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, completed the acquisition of Sonio SAS, a leading French ultrasound AI software company. The closing of the transaction was subject to applicable regulatory approvals, notably the approval of the French Ministry of the Economy and Finance. Following the completion of the transaction, Sonio will remain an independent company headquartered in France and will continue its commercial growth independently.
Sonio was established in 2020 with a mission to enhance women and children’s health globally. The company developed industry leading IT solutions and AI assistant features for obstetrics and gynaecology ultrasound that robustly assisted medical professionals in the evaluation and documentation of ultrasound exams. Sonio Detect, an FDA 510(k) cleared AI assistant, provides accurate feedback on ultrasound examination quality and demonstrates over 90% sensitivity in recognizing foetal ultrasound views. The company said Together with Samsung Medison’s ultrasound systems and Sonio’s AI expertise will help accelerate innovation in patient outcomes and quality of prenatal care.
According to Deepak Prakash, CTO and co-founder, Sonio, “Samsung's acquisition is a testament to the impact we have created thanks to the incredible tech, products and team we built in the past years. It is truly special that Indian engineers figure prominently in our exceptional team. Together, the two companies aim to bring about a transformational shift in prenatal ultrasound examinations that would especially be a game-changer in developing regions of the world including India.
Yong Kwan Kim, CEO, Samsung Medison, stated, “Through the acquisition of Sonio, we will continue to deliver upon our promise to improve the quality of people’s lives with technology.”- The collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities.”
“Samsung Medison’s established global ultrasound business combined with Sonio’s advanced AI creates an exciting growth opportunity for both sides. In addition to the close collaboration with Samsung Medison, as an independent company, we will continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare,” said Cécile Brosset, CEO and co-founder, Sonio.
|